Replies to post #217365 on Innovation Pharmaceuticals Inc (IPIX)

[Yooper61]

I don’t think you get the ROI of doing a 505(b)2 phase 3 and the increase in value of a phase 3 head to head smack down of Otezla at 12 weeks. We have no need of BP to do this. Mgmt decided to keep P back in May.